Literature DB >> 6379289

Hyperacute renal allograft rejection in the rabbit. The role of platelet-activating factor and of cationic proteins derived from polymorphonuclear leukocytes and from platelets.

S Ito, G Camussi, C Tetta, F Milgrom, G Andres.   

Abstract

The macroscopic signs of rejection, the levels of circulating transplantation antibodies, the histologic and immunocytochemical aspects, and the levels of platelet-activating factor (PAF) present in the venous blood were studied in two groups of rabbits that had received renal allografts, one group presensitized with multiple skin grafts and a second group unsensitized, as well as in a third group of rabbits that had received renal autografts. All of the eight allografts hyperacutely rejected by presensitized recipients had deposits of rabbit IgG, IgM, and C3 along the endothelia of the vessels and massive intravascular accumulation of platelets (Pt) as soon as 5 minutes after revascularization. PAF release was detected in 2 to 10 minutes after revascularization and was present throughout most of the 60 minutes of observation. Sixty minutes after transplantation Pt and polymorphonuclear leukocytes (PMN) obliterated the vasculature and deposits of Pt- and PMN-derived cationic proteins were detected in the lumina and in the walls of the capillaries. Similar, but less severe, findings were observed in three of six renal allografts which had transient episodes of rejection after transplantation into presensitized recipients. In contrast, circulating transplantation antibodies, macroscopic signs of rejection, vascular immune deposits, release of PAF, and microvascular thrombosis were not detected in renal allografts transplanted into unsensitized recipients or in renal autografts. The results indicate that in hyperacute renal allograft rejection there is an immediate fixation of transplantation antibodies and complement of the recipient to endothelial antigens of the graft, local release of PAF, and massive accumulation, aggregation, and degranulation of Pt and PMN in the vasculature, resulting in a binding of Pt- and PMN-derived cationic proteins to the walls of the capillaries. It is conceivable that PAF release and Pt and PMN cationic proteins may contribute, together with other lysosomal enzymes, vasoconstriction, and coagulation, to the pathogenesis of antibody- and complement-mediated hyperacute graft injury.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6379289

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  20 in total

1.  Platelets as participants in hyperacute guinea pig-to-rat lung xenorejection.

Authors:  M Nonaka; M Kadokura; D Kataoka; S Yamamoto; N Tanio; K Inoue; T Takaba
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

Review 2.  The present state of liver transplantation and the future prospects for intestinal transplantation.

Authors:  T E Starzl
Journal:  Immunol Invest       Date:  1989 Jan-May       Impact factor: 3.657

3.  A modified technique of orthotopic transplant of the kidney in rabbits.

Authors:  V Mazzaferro; L Makowka; F Enrichens; D Kahn; G Ferla; B Banner; G Olivero; R R Selby; W C Stevenson; S Todo
Journal:  J Invest Surg       Date:  1989       Impact factor: 2.533

4.  The effect of FK-506 on hyperacute rejection in presensitized rats.

Authors:  L Makowka; F Chapman; S Qian; A Zerbe; P H Lee; N Murase; R Saunders; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

5.  Effect of chlorpromazine on the development of experimental glomerulonephritis and Arthus reaction.

Authors:  G Camussi; G Salvidio; N Niesen; J Brentjens; G Andres
Journal:  Am J Pathol       Date:  1988-06       Impact factor: 4.307

6.  Platelet-activating factor and hyperacute rejection. The effect of a platelet-activating factor antagonist, SRI 63-441, on rejection of xenografts and allografts in sensitized hosts.

Authors:  L Makowka; F A Chapman; D V Cramer; S G Qian; H Sun; T E Starzl
Journal:  Transplantation       Date:  1990-09       Impact factor: 4.939

Review 7.  Clinical experience with platelet-activating factor antagonists. Past, present, and near future.

Authors:  P Guinot
Journal:  Clin Rev Allergy       Date:  1994

8.  Prolongation of pig-to-dog renal xenograft survival by modification of the inflammatory mediator response.

Authors:  L Makowka; C Miller; P Chapchap; L Podesta; C Pan; D Pressley; V Mazzaferro; C O Esquivel; S Todo; B Banner
Journal:  Ann Surg       Date:  1987-10       Impact factor: 12.969

9.  Glomerulonephritis induced in the rabbit by antiendothelial antibodies.

Authors:  S Matsuo; A Fukatsu; M L Taub; P R Caldwell; J R Brentjens; G Andres
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

10.  Intravascular release of a platelet-activating factor-like lipid (PAF-LL) induced by cigarette smoking.

Authors:  T Imaizumi
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.